PPARα regulates lipid metabolism, inflammation, and glucose homeostasis and has emerged as a therapeutic target for hyperlipidemia, diabetic microvascular complications, liver diseases (MASH and MAFLD), and pain [5,6,7,8]. This evidence concerns the gene PPARA and hyperlipidemia.